Avantis Inflation Focused Equity ETF Rating $62.47 +0.30 (+0.48%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsBuy This Stock Avantis Inflation Focused Equity ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.AVIE Aggregate RatingModerate Buy 2.67Holdings in AVIE have an aggregate rating of Moderate Buy based on 465 analyst ratings issued in the past year covering 25 companies (53.3% of the portfolio).AVIE Aggregate Price Target$62.47High Prediction$62.47Average Prediction$62.47Low Prediction$62.47Holdings in AVIE have an aggregate price target of $62.47 and a range of $62.47 to $62.47 covering 25 companies (53.3% of the portfolio).AVIE Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Avantis Inflation Focused Equity ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 AVIE Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.22%BRK.BBerkshire Hathaway$490.80-0.4%2.0418 of 5 stars3.00$575.00 17.2%15.08%XOMExxon Mobil$112.45+1.6%4.8326 of 5 stars2.43$124.81 11.0%21Trending NewsAnalyst Forecast3.95%LLYEli Lilly and Company$754.24+0.5%5 of 5 stars2.70$950.17 26.0%23Trending News3.81%PGProcter & Gamble$157.49-1.2%4.6976 of 5 stars2.67$175.12 11.2%18Positive News3.39%CVXChevron$157.76+1.9%4.682 of 5 stars2.36$164.80 4.5%22Positive NewsAnalyst Forecast2.75%KOCocaCola$67.83-0.1%4.7208 of 5 stars3.13$77.21 13.8%16Positive News2.59%ABBVAbbVie$211.84+0.7%4.6331 of 5 stars2.92$214.95 1.5%26Dividend Announcement2.59%PMPhilip Morris International$165.43+0.4%4.623 of 5 stars2.92$184.91 11.8%13News CoveragePositive News2.28%PEPPepsiCo$142.66-0.3%4.1817 of 5 stars2.16$158.60 11.2%19Trending News2.18%UNHUnitedHealth Group$347.27-0.2%4.835 of 5 stars2.52$355.77 2.4%25Trending NewsAnalyst ForecastOptions Volume1.71%JNJJohnson & Johnson$175.70-0.7%4.6498 of 5 stars2.65$176.29 0.3%20Trending NewsAnalyst Revision1.58%COPConocoPhillips$94.20+2.5%4.9171 of 5 stars2.80$120.86 28.3%20Analyst Forecast1.56%PGRProgressive$246.17+1.2%4.6317 of 5 stars2.50$284.82 15.7%18News CoveragePositive NewsAnalyst Forecast1.47%GILDGilead Sciences$115.24-0.5%4.9418 of 5 stars2.89$115.39 0.1%27Positive News1.35%AMGNAmgen$278.51-0.5%4.78 of 5 stars2.32$304.43 9.3%22Positive News1.31%MCKMcKesson$705.88+0.0%4.5823 of 5 stars2.85$725.10 2.7%13News CoveragePositive News1.09%MRKMerck & Co., Inc.$84.06-0.7%4.9963 of 5 stars2.35$107.44 27.8%20Positive News1.06%CLColgate-Palmolive$83.22-1.3%4.8454 of 5 stars2.55$98.00 17.8%11News CoveragePositive News0.97%VRTXVertex Pharmaceuticals$388.69-2.0%4.9657 of 5 stars2.56$497.10 27.9%27Positive News0.97%NEMNewmont$78.48+3.4%4.4039 of 5 stars2.71$67.38 -14.1%21Analyst Upgrade0.91%EOGEOG Resources$120.17+2.4%4.4701 of 5 stars2.54$143.52 19.4%24Positive News0.90%KMBKimberly-Clark$128.13-2.2%4.6866 of 5 stars2.20$142.70 11.4%10News CoveragePositive News0.89%FCXFreeport-McMoRan$44.89+2.3%4.8528 of 5 stars2.67$51.00 13.6%18News CoveragePositive News0.86%ELVElevance Health$307.01-2.0%4.735 of 5 stars2.67$411.06 33.9%180.86%CORCencora$296.38-0.8%4.4567 of 5 stars2.75$311.25 5.0%12News CoveragePositive News This page (NYSEARCA:AVIE) was last updated on 9/10/2025 by MarketBeat.com Staff From Our PartnersNVDA: The cracks are beginning to showThe media hasn't caught up to the story yet, but when they do, this stock could leave Nvidia in the dust. I...InvestorPlace | SponsoredOne tiny company just cracked Google’s $19B problemTucked away outside San Antonio sits a facility most Americans don’t know exists. It’s not mining gold or o...True Market Insiders | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avantis Inflation Focused Equity ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Avantis Inflation Focused Equity ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
